Literature DB >> 2123822

Lymphocyte receptors for pertussis toxin.

C G Clark1, G D Armstrong.   

Abstract

We have investigated human T-lymphocyte receptors for pertussis toxin by affinity isolation and photoaffinity labeling procedures. T lymphocytes were obtained from peripheral human blood, surface iodinated, and solubilized in Triton X-100. The iodinated mixture was then passed through pertussis toxin-agarose, and the fractions were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Autoradiography of the fixed, dried gels revealed several bands in the pertussis toxin-bound fraction that were not observed in fractions obtained from histone or fetuin-agarose. Further investigations employed a photoaffinity labeling reagent, sulfosuccinimidyl 2-(p-azido-salicylamido)-1,3'-dithiopropionate, to identify pertussis toxin receptors in freshly isolated peripheral blood monocytic cells, T lymphocytes, and Jurkat cells. In all three cell systems, the pertussis toxin affinity probe specifically labeled a single protein species with an apparent molecular weight of 70,000 that was not observed when the procedure was performed in the presence of excess unmodified pertussis toxin. A protein comparable in molecular weight to the one detected by the photoaffinity labeling technique was also observed among the species that bound to pertussis toxin-agarose. The results suggest that pertussis toxin may bind to a 70,000-Da receptor in human T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123822      PMCID: PMC313744          DOI: 10.1128/iai.58.12.3840-3846.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Pertussis toxin effects on T lymphocytes are mediated through CD3 and not by pertussis toxin catalyzed modification of a G protein.

Authors:  L S Gray; K S Huber; M C Gray; E L Hewlett; V H Engelhard
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

2.  The use of sulfosuccinimidyl-2-(p-azidosalicylamido)-1,3'-dithiopropionate as a crosslinking reagent to identify cell surface receptors.

Authors:  E G Shephard; F C de Beer; C von Holt; J P Hapgood
Journal:  Anal Biochem       Date:  1988-02-01       Impact factor: 3.365

3.  Human T lymphocyte mitogenesis in response to the B oligomer of pertussis toxin is associated with an early elevation in cytosolic calcium concentrations.

Authors:  C F Strnad; R A Carchman
Journal:  FEBS Lett       Date:  1987-12-10       Impact factor: 4.124

4.  Specific endotoxic lipopolysaccharide-binding proteins on murine splenocytes. II. Membrane localization and binding characteristics.

Authors:  M G Lei; D C Morrison
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

5.  Interactive effects of pertussis toxin and the phorbol ester tumour promotor, phorbol dibutyrate, on T-lymphocyte mitogenesis and the expression of phenotypic determinants.

Authors:  C F Strnad; W Q Lin; R A Carchman
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

6.  Pertussis toxin activates protein kinase C and a tyrosine protein kinase in the human T cell line Jurkat.

Authors:  R E Thom; J E Casnellie
Journal:  FEBS Lett       Date:  1989-02-13       Impact factor: 4.124

7.  Lectinlike properties of pertussis toxin.

Authors:  G J Tyrrell; M S Peppler; R A Bonnah; C G Clark; P Chong; G D Armstrong
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

8.  The effects of pertussis toxin on human T lymphocytes.

Authors:  E A Macintyre; P E Tatham; R Abdul-Gaffar; D C Linch
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

9.  Specific endotoxic lipopolysaccharide-binding proteins on murine splenocytes. I. Detection of lipopolysaccharide-binding sites on splenocytes and splenocyte subpopulations.

Authors:  M G Lei; D C Morrison
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

10.  Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells.

Authors:  E Tuomanen; H Towbin; G Rosenfelder; D Braun; G Larson; G C Hansson; R Hill
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  8 in total

1.  Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages.

Authors:  J van't Wout; W N Burnette; V L Mar; E Rozdzinski; S D Wright; E I Tuomanen
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

2.  Pertussis toxin activates platelets through an interaction with platelet glycoprotein Ib.

Authors:  K A Sindt; E L Hewlett; G T Redpath; R Rappuoli; L S Gray; S R Vandenberg
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

3.  Evidence that lipopolysaccharide and pertussis toxin bind to different domains on the same p73 receptor on murine splenocytes.

Authors:  M G Lei; D C Morrison
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

4.  Interaction of pertussis toxin with human T lymphocytes.

Authors:  M H Witvliet; M L Vogel; E J Wiertz; J T Poolman
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

5.  The 70-kilodalton pertussis toxin-binding protein in Jurkat cells.

Authors:  G D Armstrong; C G Clark; L D Heerze
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains.

Authors:  M Alfano; H Schmidtmayerova; C A Amella; T Pushkarsky; M Bukrinsky
Journal:  J Exp Med       Date:  1999-09-06       Impact factor: 14.307

7.  Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin.

Authors:  Y Lobet; C Feron; G Dequesne; E Simoen; P Hauser; C Locht
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

8.  Prokaryotic peptides that block leukocyte adherence to selectins.

Authors:  E Rozdzinski; W N Burnette; T Jones; V Mar; E Tuomanen
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.